Oocyte donor selection from 554 candidates.

Oocyte donation is a technique in full expansion in the field of human reproduction. The main problem with this technique is the shortage of oocytes. In our programme, prospective donors are selected from anonymous, well-informed university students over 18 years of age, who give their informed consent in writing. Before being accepted as donors, the candidates' personal and family medical histories were taken and they were given a gynaecological examination, genital ultrasonography, and analysed for syphilis, acquired immune deficiency syndrome, hepatitis B and C, coagulation factor VIII, fetal haemoglobin and karyotype. The donors received economic compensation of about 750 euros. Over the last 6 years, 554 medical histories have been taken. Fifty-eight candidates (10.5%) were rejected because of previous family or personal pathologies. Only 243 out of 496 (49%) continued the study. Sixteen candidates (7%) were rejected as a result of gynaecological problems and ultrasonographic results; and 12 (4.9%) as a result of their blood test results; 215 donors were accepted (38.8% of the original population). Other options for recruiting oocyte donors are commented on and we argue that the methodology described here is the most suitable one.

[1]  E. Simons,et al.  Money, morals and medical risks: conflicting notions underlying the recruitment of egg donors. , 1999, Human reproduction.

[2]  R. Landau.  The management of genetic origins: secrecy and openness in donor assisted conception in Israel and elsewhere. , 1998, Human reproduction.

[3]  E. Simons,et al.  An assessment of the motives and morals of egg share donors: policy of 'payments' to egg donors requires a fair review. , 1998, Human reproduction.

[4]  H. Abdalla,et al.  A survey of anonymous oocyte donors: demographics. , 1998, Human reproduction.

[5]  J. Guérin.  The donation of gametes is possible without paying donors: experience of the French CECOS Federation. Centre for the cryopreservation of eggs and semen. , 1998, Human reproduction.

[6]  E. McLaughlin,et al.  Recruitment of gamete donors and payment of expenses. , 1998, Human reproduction.

[7]  F. Shenfield,et al.  Recruitment and counselling of sperm donors: ethical problems. , 1998, Human reproduction.

[8]  R. Deech.  Legal and ethical responsibilities of gamete banks. , 1998, Human reproduction.

[9]  J. Gunning.  Oocyte donation: the legislative framework in Western Europe. , 1998, Human reproduction.

[10]  S. Lindheim.  Indications, Success Rates, and Outcomes , 1998 .

[11]  M. J. Gorrill.  Selection and Screening of Potential Oocyte Donors , 1998 .

[12]  R. Morris.  Complications and Side Effects of Oocyte Donation , 1998 .

[13]  E. Simons,et al.  Egg-sharing in assisted conception: ethical and practical considerations. , 1996, Human reproduction.

[14]  V. Söderström-Anttila.  Follow-up study of Finnish volunteer oocyte donors concerning their attitudes to oocyte donation. , 1995, Human reproduction.

[15]  N. Amso.  Potential health hazards of assisted reproduction continued: Problems facing the clinician , 1995 .

[16]  M. Sauer,et al.  Oocyte and embryo donation. , 1995, Current opinion in obstetrics & gynecology.

[17]  N. Amso.  Potential health hazards of assisted reproduction. Problems facing the clinician. , 1995, Human reproduction.

[18]  S. Self,et al.  Ovarian tumors in a cohort of infertile women. , 1994, The New England journal of medicine.

[19]  R. Paulson,et al.  Mishaps and misfortunes: complications that occur in oocyte donation. , 1994, Fertility and sterility.

[20]  Z. Ben-Rafael,et al.  Acute pelvic inflammatory disease after oocyte retrieval: adverse effects on the results of implantation. , 1994, Fertility and sterility.

[21]  C. Versaci,et al.  Oocyte donation in menopausal women. , 1993, Human reproduction.

[22]  D. Meldrum.  Female reproductive aging — Ovarian and uterine factors , 1993, Fertility and sterility.

[23]  Z. Ben-Rafael,et al.  Severe abdominal complications after transvaginal ultrasonographically guided retrieval of oocytes for in vitro fertilization and embryo transfer. , 1993, Fertility and sterility.

[24]  A. Braverman.  Survey results on the current practice of ovum donation , 1993 .

[25]  J. Remohi,et al.  Oocyte donation in low responders to conventional ovarian stimulation for in vitro fertilization. , 1993, Fertility and sterility.

[26]  L. Veeck,et al.  Significantly enhanced pregnancy rates per cycle through cryopreservation and thaw of pronuclear stage oocytes. , 1993, Fertility and sterility.

[27]  M. Seibel,et al.  Compensating egg donors: equal pay for equal time? , 1993, The New England journal of medicine.

[28]  L. Veeck,et al.  Basal follicle-stimulating hormone level and age affect the chance for and outcome of pre-embryo cryopreservation. , 1993, Fertility and sterility.

[29]  J Halpern,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. I. Methods. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[30]  A. Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[31]  A. Fagot-Largeault.  Human fertilisation and Embryology Authority , 1992, The Lancet.

[32]  B. V. Van Voorhis,et al.  Use of oocytes from anonymous, matched, fertile donors for prevention of heritable genetic diseases. , 1992, Journal of medical genetics.

[33]  R. Paulson,et al.  Oocyte donors: a demographic analysis of women at the University of Southern California. , 1992, Human reproduction.

[34]  R. Collins,et al.  Establishment of an Oocyte Donor Program , 1991, Annals of the New York Academy of Sciences.

[35]  R. Casper,et al.  Transvaginal, ultrasound-guided oocyte retrieval for in vitro fertilization. , 1989, The Journal of reproductive medicine.

[36]  D. Barad,et al.  Availability of donated oocytes from an ambulatory sterilization program. , 1989, The Journal of reproductive medicine.

[37]  Z. Rosenwaks.  Donor eggs: their application in modern reproductive technologies. , 1987, Fertility and sterility.

[38]  J. Annegers,et al.  Incidence of Premature Ovarian Failure , 1986, Obstetrics and gynecology.

[39]  Lütjen Pj,et al.  Oocyte and embryo donation in IVF programmes. , 1985 .

[40]  J. Leeton,et al.  Oocyte and embryo donation in IVF programmes. , 1985, Clinics in obstetrics and gynaecology.

[41]  A. Trounson,et al.  The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure , 1984, Nature.